A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines by more than half.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These are the key takeaways.

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co.

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs actually work.

Many common prescription drugs block the body’s ability to keep us cool.

Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s what to know ...